• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米颗粒与纳米材料:从药学与医学角度的综述

Nanoparticles and Nanomaterials: A Review from the Standpoint of Pharmacy and Medicine.

作者信息

Petrov Gleb V, Koldina Alena M, Ledenev Oleg V, Tumasov Vladimir N, Nazarov Aleksandr A, Syroeshkin Anton V

机构信息

Department of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia.

Department of Biology, Lomonosov Moscow State University, Leninskie Gory, 119234 Moscow, Russia.

出版信息

Pharmaceutics. 2025 May 16;17(5):655. doi: 10.3390/pharmaceutics17050655.

DOI:10.3390/pharmaceutics17050655
PMID:40430945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12114779/
Abstract

Nanoparticles (NPs) represent a unique class of structures in the modern world. In comparison to macro- and microparticles, NPs exhibit advantages due to their physicochemical properties. This has resulted in their extensive application not only in technical and engineering sciences, but also in pharmacy and medicine. A recent analysis of the scientific literature revealed that the number of articles related to the search term "nanoparticle drugs" has exceeded 65,000 in the last decade alone, according to PubMed. The growth of scientific publications on NPs and nanomaterials (NMs) in pharmacy demonstrates the rapidly developing interest of scientists in exploring alternative ways to deliver drugs, thereby improving their pharmacokinetic and pharmacodynamic properties, and the increased biocompatibility of many nanopharmaceuticals is a unique key to two mandatory pharmaceutical requirements-drug efficacy and safety. A comprehensive review of the literature indicates that the modern pharmaceutical industry is increasingly employing nanostructures. The exploration of their physicochemical properties with a subsequent modern approach to quality control remains the main task of modern pharmaceutical chemistry. The primary objective of this review is to provide a comprehensive overview of data on NPs, their physicochemical properties, and modern approaches to their synthesis, modification of their surface, and application in pharmacy.

摘要

纳米颗粒(NPs)是现代世界中一类独特的结构。与宏观和微观颗粒相比,纳米颗粒因其物理化学性质而具有优势。这使得它们不仅在技术和工程科学领域,而且在药学和医学领域都得到了广泛应用。最近对科学文献的分析表明,仅在过去十年中,根据PubMed的数据,与搜索词“纳米颗粒药物”相关的文章数量就已超过65000篇。药学领域关于纳米颗粒和纳米材料(NMs)的科学出版物的增长表明,科学家们对探索药物递送的替代方法的兴趣迅速增长,从而改善药物的药代动力学和药效学性质,并且许多纳米药物生物相容性的提高是满足药物疗效和安全性这两个强制性药学要求的独特关键。对文献的全面综述表明,现代制药行业越来越多地采用纳米结构。利用后续现代质量控制方法探索其物理化学性质仍然是现代药物化学的主要任务。本综述的主要目的是全面概述有关纳米颗粒的数据、其物理化学性质以及其合成、表面修饰和在药学中的应用的现代方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/fd776a8f75e2/pharmaceutics-17-00655-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/2cc4af09fab5/pharmaceutics-17-00655-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/5e7115b967be/pharmaceutics-17-00655-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/89e83c62df61/pharmaceutics-17-00655-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/4b09fc2c404a/pharmaceutics-17-00655-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/1d5fdad68cd8/pharmaceutics-17-00655-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/a820239861e4/pharmaceutics-17-00655-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/e030d8dd7774/pharmaceutics-17-00655-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/94ae5ad5f5cc/pharmaceutics-17-00655-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/b9a99e90bda7/pharmaceutics-17-00655-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/d10c095b7eea/pharmaceutics-17-00655-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/465249d01c36/pharmaceutics-17-00655-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/8f08cd3a2a20/pharmaceutics-17-00655-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/975e54bac217/pharmaceutics-17-00655-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/65334bf137e9/pharmaceutics-17-00655-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/6e1da9e91a25/pharmaceutics-17-00655-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/efba44018ad3/pharmaceutics-17-00655-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/848ec575d2da/pharmaceutics-17-00655-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/e107eb4b131a/pharmaceutics-17-00655-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/9a521ddeb373/pharmaceutics-17-00655-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/4bfc2db8cc0d/pharmaceutics-17-00655-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/fd776a8f75e2/pharmaceutics-17-00655-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/2cc4af09fab5/pharmaceutics-17-00655-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/5e7115b967be/pharmaceutics-17-00655-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/89e83c62df61/pharmaceutics-17-00655-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/4b09fc2c404a/pharmaceutics-17-00655-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/1d5fdad68cd8/pharmaceutics-17-00655-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/a820239861e4/pharmaceutics-17-00655-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/e030d8dd7774/pharmaceutics-17-00655-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/94ae5ad5f5cc/pharmaceutics-17-00655-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/b9a99e90bda7/pharmaceutics-17-00655-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/d10c095b7eea/pharmaceutics-17-00655-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/465249d01c36/pharmaceutics-17-00655-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/8f08cd3a2a20/pharmaceutics-17-00655-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/975e54bac217/pharmaceutics-17-00655-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/65334bf137e9/pharmaceutics-17-00655-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/6e1da9e91a25/pharmaceutics-17-00655-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/efba44018ad3/pharmaceutics-17-00655-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/848ec575d2da/pharmaceutics-17-00655-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/e107eb4b131a/pharmaceutics-17-00655-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/9a521ddeb373/pharmaceutics-17-00655-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/4bfc2db8cc0d/pharmaceutics-17-00655-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80f/12114779/fd776a8f75e2/pharmaceutics-17-00655-g021.jpg

相似文献

1
Nanoparticles and Nanomaterials: A Review from the Standpoint of Pharmacy and Medicine.纳米颗粒与纳米材料:从药学与医学角度的综述
Pharmaceutics. 2025 May 16;17(5):655. doi: 10.3390/pharmaceutics17050655.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.表面改性纳米材料在癌症诊疗中的应用进展
Curr Drug Metab. 2017;18(11):983-999. doi: 10.2174/1389200218666171002122039.
4
Innovative Applications of Plant Viruses in Drug Targeting and Molecular Imaging- A Review.植物病毒在药物靶向和分子成像中的创新应用——综述。
Curr Med Imaging. 2021;17(4):491-506. doi: 10.2174/1573405616666201007160243.
5
Nanoformulations in Pharmaceutical and Biomedical Applications: Green Perspectives.纳米制剂在药物和生物医学应用中的应用:绿色视角。
Int J Mol Sci. 2024 May 27;25(11):5842. doi: 10.3390/ijms25115842.
6
Advances in inorganic nanoparticles-based drug delivery in targeted breast cancer theranostics.基于无机纳米粒子的药物递送至靶向乳腺癌治疗学的新进展。
Adv Colloid Interface Sci. 2024 Jul;329:103204. doi: 10.1016/j.cis.2024.103204. Epub 2024 May 22.
7
Zinc Oxide Nanoparticles in Modern Science and Technology: Multifunctional Roles in Healthcare, Environmental Remediation, and Industry.现代科学技术中的氧化锌纳米颗粒:在医疗保健、环境修复和工业中的多功能作用
Nanomaterials (Basel). 2025 May 17;15(10):754. doi: 10.3390/nano15100754.
8
[Historical sketch of modern pharmaceutical science and technology (Part 3). From the second half of the 19th century to World War II].[现代制药科学技术史略(第3部分)。从19世纪下半叶到第二次世界大战]
Yakushigaku Zasshi. 1995;30(1):1-10.
9
Cancer treatment and toxicity outlook of nanoparticles.纳米颗粒的癌症治疗与毒性展望
Environ Res. 2023 Nov 15;237(Pt 1):116870. doi: 10.1016/j.envres.2023.116870. Epub 2023 Aug 9.
10
Advances in Nanomaterials for Targeted Drug Delivery: Emerging Trends and Future Prospects in Nanodrug Development.用于靶向给药的纳米材料进展:纳米药物开发的新兴趋势与未来前景
Curr Cancer Drug Targets. 2025 Mar 12. doi: 10.2174/0115680096362452250301054711.

本文引用的文献

1
Approved natural products-derived nanomedicines for disease treatment.已批准的用于疾病治疗的天然产物衍生纳米药物。
Chin J Nat Med. 2024 Dec;22(12):1100-1116. doi: 10.1016/S1875-5364(24)60726-0.
2
Pristine B fullerene as a potential gemcitabine drug carrier for anti-lung cancer properties: a DFT and QTAIM study.原始B富勒烯作为具有抗肺癌特性的潜在吉西他滨药物载体:一项密度泛函理论和量子拓扑原子分子理论研究
J Biomol Struct Dyn. 2024 Nov 23:1-14. doi: 10.1080/07391102.2024.2431665.
3
Immunogenicity and protection of a triple repeat domain III mRNA vaccine against Zika virus.
一种针对寨卡病毒的三重重复结构域III mRNA疫苗的免疫原性及保护作用
Vaccine. 2025 Jan 1;43(Pt 2):126518. doi: 10.1016/j.vaccine.2024.126518. Epub 2024 Nov 14.
4
Highly Stable Biotemplated InP/ZnSe/ZnS Quantum Dots for Bacterial Monitoring.用于细菌监测的高度稳定的生物模板化InP/ZnSe/ZnS量子点
ACS Appl Mater Interfaces. 2024 Oct 16;16(41):55086-55096. doi: 10.1021/acsami.4c09968. Epub 2024 Oct 7.
5
Strategies for Non-Covalent Attachment of Antibodies to PEGylated Nanoparticles for Targeted Drug Delivery.抗体与聚乙二醇化纳米颗粒的非共价连接策略用于靶向药物递送。
Int J Nanomedicine. 2024 Oct 1;19:10045-10064. doi: 10.2147/IJN.S479270. eCollection 2024.
6
Effects of nanoparticle size, shape, and zeta potential on drug delivery.纳米颗粒的大小、形状和 Zeta 电位对药物传递的影响。
Int J Pharm. 2024 Dec 5;666:124799. doi: 10.1016/j.ijpharm.2024.124799. Epub 2024 Oct 5.
7
A Comprehensive Review of Nanoparticles: From Classification to Application and Toxicity.纳米粒子综述:从分类到应用和毒性。
Molecules. 2024 Jul 25;29(15):3482. doi: 10.3390/molecules29153482.
8
Improved anti-breast cancer activity by doxorubicin-loaded super stealth liposomes.载多柔比星的超超顺磁性脂质体提高了抗乳腺癌活性。
Biomater Sci. 2024 Jul 23;12(15):3933-3946. doi: 10.1039/d4bm00478g.
9
Development, production and characterization of SARS-CoV-2 virus-like particles (Coronaviridae: ).SARS-CoV-2 病毒样颗粒(冠状病毒科: )的开发、生产和特性描述。
Vopr Virusol. 2024 May 6;69(2):175-186. doi: 10.36233/0507-4088-226.
10
Self-Immolative Domino Dendrimers as Anticancer-Drug Delivery Systems: A Review.作为抗癌药物递送系统的自牺牲型多米诺树枝状大分子:综述
Pharmaceutics. 2024 May 16;16(5):668. doi: 10.3390/pharmaceutics16050668.